News

Levoleucovorin is indicated after high-dose methotrexate therapy in patients with osteosarcoma, and to diminish the toxicity and counteract the effects of impaired methotrexate elimination or inadvertent overdose of

The American Association of Retired Persons or AARP contended that the prices charged to wholesalers and direct buyers was high but the burden was not felt due to

Rx&D, the Canadian research-based pharmaceutical industry association has welcomed the government’s investment plan unveiled in the federal budget on February 26, 2008. The Canadian government also intends to

The EAEPC contended that the Spanish medicines law of 2006, which allows pharmaceutical companies to adopt differential pricing depending on whether the product is going be sold domestically

The company, a spin-off from the University of Michigan, has received a total of $30 million over the past 18 months from Perseus, a private equity management firm.

The submission is based on the recently completed Phase II/III prospective, double-blind placebo-controlled International Multi- center Prospective Angioedema C1-Inhibitor Trial (IMPACT), the largest HAE trial ever, that studied

The transaction will bring together three medically meaningful therapies, Revlimid, Thalomid and Vidaza, treating patients worldwide. These products are expected to generate multiple global revenue streams for accelerated

The pharmacokinetic (PK) studies demonstrated that Protexia had a half life of approximately four days in primates and three days in rodents when administered by intramuscular injection. These

An aggregate of 8.14 million shares of common stock and warrants for the purchase of an aggregate of 4.07 million shares of common stock will be issued by